FDA.reportPublic FDA data

Praluent

Product NDC
0024-5904
11-digit product format
000245904
Labeler code
0024
Product ID
0024-5904_d6e3eeb8-c775-4382-85c3-3f3e8999c280
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
alirocumab
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
Sanofi-Aventis U.S. LLC
Application
BLA125559
Marketing category
BLA
Marketing start
2015-07-24
Marketing end
0000-00-00
Substance
ALIROCUMAB
Active strength
150 mg/mL
Pharmacologic classes
PCSK9 Inhibitor [EPC],PCSK9 Inhibitors [MoA],Antibodies, Monoclonal [CS]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0024-5904DDiscontinued by firm2026-07-31
excluded packagepackage0024-59040024-5904-00DDiscontinued by firm2026-07-31
excluded packagepackage0024-59040024-5904-01DDiscontinued by firm2026-07-31
excluded packagepackage0024-59040024-5904-02DDiscontinued by firm2026-07-31

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PraluentALIROCUMABRegeneron Pharmaceuticals, Inc.7bcfbac2-e8ac-4569-8edc-bcde3b1fd1722026-07-16Warnings, Adverse reactionsExact identifier
application number: BLA125559
PraluentALIROCUMABSanofi-Aventis U.S. LLC446f6b5c-0dd4-44ff-9bc2-c2b41f2806b42026-07-07Warnings, Adverse reactionsExact identifier
application number: BLA125559
ndc (product): 0024-5904

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ab434c1f-2b4e-461c-92e8-506132dea02aProduct name120190716
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0024-5904-002024-01-30C16284748780-11030e365-3cfe-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
0024-5904-002024-01-30C16284748780-11030e365-3cfe-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
0024-5904-002024-01-30C16284748780-11030e365-3cfe-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
0024-5904-012024-01-30C16284748780-11030e365-3cfe-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
0024-5904-012024-01-30C16284748780-11030e365-3cfe-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
0024-5904-012024-01-30C16284748780-11030e365-3cfe-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
0024-5904-022024-01-30C16284748780-11030e365-3cfe-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
0024-5904-022024-01-30C16284748780-11030e365-3cfe-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015
0024-5904-022024-01-30C16284748780-11030e365-3cfe-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0024-5904-00Praluent1 in 1 BLISTER PACKINJECTION, SOLUTION133
0024-5904-00Praluent1 in 1 CARTONINJECTION, SOLUTION133
0024-5904-01Praluent1 in 1 CARTONINJECTION, SOLUTION133
0024-5904-01Praluent1 in 1 BLISTER PACKINJECTION, SOLUTION133
0024-5904-02Praluent2 in 1 CARTONINJECTION, SOLUTION233
0024-5904-02Praluent1 in 1 BLISTER PACKINJECTION, SOLUTION133

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0024-5904-01ML - Milliliter0024-5904ae1387ab-fd37-4681-b04b-705432cfb43912015-09-10
0024-5904-02ML - Milliliter0024-5904e8b7f70f-1a45-43f9-be2b-5258aa1fbd2612015-08-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
alirocumabACTIVE INGREDIENTPP0SHH6V16PRALUENT (ALIROCUMAB) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]1
alirocumabACTIVE MOIETYPP0SHH6V16PRALUENT (ALIROCUMAB) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]1
histidineINACTIVE INGREDIENT4QD397987EPRALUENT (ALIROCUMAB) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]1
polysorbate 20INACTIVE INGREDIENT7T1F30V5YHPRALUENT (ALIROCUMAB) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]1
sucroseINACTIVE INGREDIENTC151H8M554PRALUENT (ALIROCUMAB) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]1
waterINACTIVE INGREDIENT059QF0KO0RPRALUENT (ALIROCUMAB) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0024-5904PRALUENT (ALIROCUMAB) INJECTION, SOLUTION [SANOFI-AVENTIS U.S. LLC]31Legacy NDC, 6 package rows20240912_446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4.zip

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125559Praluentalirocumab351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1659156alirocumab 150 MG in 1 ML Auto-InjectorPSN446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659165alirocumab 150 MG in 1 ML Prefilled SyringePSN446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659182alirocumab 75 MG in 1 ML Auto-InjectorPSN446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659177alirocumab 75 MG in 1 ML Prefilled SyringePSN446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659161Praluent 150 MG in 1 ML Auto-InjectorPSN446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659167Praluent 150 MG in 1 ML Prefilled SyringePSN446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659183Praluent 75 MG in 1 ML Auto-InjectorPSN446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659179Praluent 75 MG in 1 ML Prefilled SyringePSN446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591611 ML alirocumab 150 MG/ML Auto-Injector [Praluent]SBD446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591671 ML alirocumab 150 MG/ML Prefilled Syringe [Praluent]SBD446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591831 ML alirocumab 75 MG/ML Auto-Injector [Praluent]SBD446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591791 ML alirocumab 75 MG/ML Prefilled Syringe [Praluent]SBD446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591561 ML alirocumab 150 MG/ML Auto-InjectorSCD446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591651 ML alirocumab 150 MG/ML Prefilled SyringeSCD446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591821 ML alirocumab 75 MG/ML Auto-InjectorSCD446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591771 ML alirocumab 75 MG/ML Prefilled SyringeSCD446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591611 ML Praluent 150 MG/ML Auto-InjectorSY446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591671 ML Praluent 150 MG/ML Prefilled SyringeSY446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591831 ML Praluent 75 MG/ML Auto-InjectorSY446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
16591791 ML Praluent 75 MG/ML Prefilled SyringeSY446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659156alirocumab 150 MG per 1 ML Auto-InjectorSY446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659182alirocumab 75 MG per 1 ML Auto-InjectorSY446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659161Praluent 150 MG per 1 ML Auto-InjectorSY446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659183Praluent 75 MG per 1 ML Auto-InjectorSY446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433
1659179Praluent 75 MG per 1 ML Prefilled SyringeSY446f6b5c-0dd4-44ff-9bc2-c2b41f2806b433

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
0024-5904-00000245904001 in 1 BLISTER PACKHistorical
0024-5904-01000245904011 in 1 CARTONHistorical
0024-5904-02000245904022 in 1 CARTONHistorical